CO205 Evaluating Disease-Free Survival (DFS) As a Surrogate Endpoint (SE) for Overall Survival (OS) in Muscle-Invasive Urothelial Carcinoma (MIUC): An Analysis of Surveillance, Epidemiology, and End Results (SEER)-Medicare Data

Abstract

To assess DFS as an SE for OS in adults with MIUC who have undergone radical resection using SEER-Medicare registry data.